Tumorigenicity and prediction of clinical prognosis of patient‐derived gastric cancer organoids

T. H. Wang(King Center), Ye‐Guang Chen(First Affiliated Hospital of Jiangxi Medical College), Wanlu Song(Tsinghua University), Qingyu Meng(Chinese PLA General Hospital), Yalong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaohua Guo(Chinese PLA General Hospital), Baoqing Jia(Chinese PLA General Hospital), Chuanqing Qu(King Center), Ronghui Tan(Guangzhou University)
Clinical and Translational Medicine
February 1, 2024
10.1002/ctm2.1588
Cited by 6

Related Papers

Controlling TGF-β signaling
|Genes & Development|2000|1.6k
TGF-β Signaling from Receptors to Smads
|Cold Spring Harbor Perspectives in Biology|2016|868
Dishevelled: The hub of Wnt signaling
|Cellular Signalling|2009|751
Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12
|Cell|1999|443
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436